Tempel Wolfram, Grabovec Irina, MacKenzie Farrell, Dichenko Yaroslav V, Usanov Sergey A, Gilep Andrei A, Park Hee-Won, Strushkevich Natallia
Structural Genomics Consortium, University of Toronto, Toronto, Ontario, M5G 1L7, Canada.
Institute of Bioorganic Chemistry NAS of Belarus, Minsk, 220141 Belarus.
J Lipid Res. 2014 Sep;55(9):1925-32. doi: 10.1194/jlr.M050765. Epub 2014 Jun 13.
Hepatic conversion to bile acids is a major elimination route for cholesterol in mammals. CYP7A1 catalyzes the first and rate-limiting step in classic bile acid biosynthesis, converting cholesterol to 7α-hydroxycholesterol. To identify the structural determinants that govern the stereospecific hydroxylation of cholesterol, we solved the crystal structure of CYP7A1 in the ligand-free state. The structure-based mutation T104L in the B' helix, corresponding to the nonpolar residue of CYP7B1, was used to obtain crystals of complexes with cholest-4-en-3-one and with cholesterol oxidation product 7-ketocholesterol (7KCh). The structures reveal a motif of residues that promote cholest-4-en-3-one binding parallel to the heme, thus positioning the C7 atom for hydroxylation. Additional regions of the binding cavity (most distant from the access channel) are involved to accommodate the elongated conformation of the aliphatic side chain. Structural complex with 7KCh shows an active site rigidity and provides an explanation for its inhibitory effect. Based on our previously published data, we proposed a model of cholesterol abstraction from the membrane by CYP7A1 for metabolism. CYP7A1 structural data provide a molecular basis for understanding of the diversity of 7α-hydroxylases, on the one hand, and cholesterol-metabolizing enzymes adapted for their specific activity, on the other hand.
在哺乳动物中,肝脏将胆固醇转化为胆汁酸是胆固醇的主要排泄途径。CYP7A1催化经典胆汁酸生物合成的第一步及限速步骤,将胆固醇转化为7α-羟基胆固醇。为了确定控制胆固醇立体特异性羟基化的结构决定因素,我们解析了无配体状态下CYP7A1的晶体结构。基于结构在B'螺旋中引入对应于CYP7B1非极性残基的突变T104L,用于获得与胆甾-4-烯-3-酮以及胆固醇氧化产物7-酮胆固醇(7KCh)的复合物晶体。这些结构揭示了一组促进胆甾-4-烯-3-酮平行于血红素结合的残基基序,从而将C7原子定位用于羟基化。结合腔的其他区域(离通道入口最远)参与容纳脂肪族侧链的伸长构象。与7KCh的结构复合物显示出活性位点的刚性,并解释了其抑制作用。基于我们之前发表的数据,我们提出了CYP7A1从膜中提取胆固醇进行代谢的模型。CYP7A1的结构数据一方面为理解7α-羟化酶的多样性提供了分子基础,另一方面也为适应其特定活性的胆固醇代谢酶提供了分子基础。